Users Stopping Anti-Obesity Jabs Regain Pounds Four Times Faster Than People Using Diet and Exercise

Illustration of pharmaceutical injection and weighing machine
Weight management often requires ongoing approaches.

A recent study indicates that patients who come off blockbuster slimming jabs like Wegovy and Mounjaro may regain reduced body mass at a significantly accelerated pace than those who stop conventional lifestyle plans.

Findings released in a leading medical journal shows that while obese individuals frequently drop substantial amounts of their body weight while on the medication, the weight returns at an estimated rate of 0.8 kg per month after stopping.

"Users purchasing these drugs should be informed of the danger of rapid weight regain when the therapy ends," cautioned researcher Dr. Susan Jebb.

Such speed of regain means a return to starting mass in about 18 months.

Comparing Approaches

The research, which looked at 37 of studies involving thousands of patients, compared the results of the injectable medications with older methods.

Scientists point out that individuals who lose weight through dieting typically see a more gradual creep back—around 0.1 kg a month—once they finish.

The Reason for the Rapid Rebound

Nutrition scientists propose the way of the jabs explains the heightened weight return.

The injections copy a body's own chemical called glucagon-like peptide-1, which moderates appetite.

"Sustained high doses of the hormone levels several times higher than the body's typical production may cause the body to generate a reduced amount of its own natural hormone, and may also reduce responsiveness to its effects," explained Dr. Adam Collins, a nutrition researcher.

"Stopping of this GLP-1 'fix' leads to hunger is no longer kept in check, making binge eating far more likely."

A Chronic Disease?

Health authorities advise the jabs for individuals with obesity-related health risks, accompanied by prescribed lifestyle changes.

A number of clinicians contend that, considering the significant potential of weight regain, the treatment is often long-term.

This opinion is echoed by drug manufacturers, who note that the results "underscore the persistent nature of excess weight," comparing it to managing conditions like diabetes.

Patient Testimonies

Users who have come off the jabs explain a intense return of hunger.

"I experienced something activating and I was suddenly ravenous," described one woman.

This difficulty is worsened if users have not developed sustainable lifestyle or habit changes during treatment.

Widespread Adoption

Recent estimates suggest that millions of people in the UK have tried these injections in the last 12 months, with demand being substantial.

  • Adoption is higher among women compared to men.
  • The middle-aged demographic shows the highest usage rates.
  • A large proportion access the drugs through private healthcare rather than the NHS.

In conclusion, clinicians stress that while the jabs are potent tools for weight loss, they are not a standalone solution and lasting health benefits likely depends on ongoing lifestyle management.

Gabrielle Bush
Gabrielle Bush

A seasoned gambling analyst with over a decade of experience in reviewing online casinos and slot games across Canada.